CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)
- 30 September 2000
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 29 (1) , 49
- https://doi.org/10.1016/s0169-5002(00)80158-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: